HEADER HYDROLASE/VIRAL PROTEIN 06-FEB-23 8I9H TITLE S-RBD (OMICRON XBB.1) IN COMPLEX WITH PD OF ACE2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROCESSED ANGIOTENSIN-CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: SPIKE PROTEIN S2'; COMPND 7 CHAIN: E; COMPND 8 FRAGMENT: RBD; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: OMICRON XBB.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE2, UNQ868/PRO1885; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 10 2; SOURCE 11 ORGANISM_TAXID: 2697049; SOURCE 12 GENE: S, 2; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, VIRAL PROTEIN, HYDROLASE-VIRAL PROTEIN COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR Y.N.LI,Y.P.SHEN,Y.Y.ZHANG,R.H.YAN REVDAT 3 30-OCT-24 8I9H 1 REMARK REVDAT 2 21-AUG-24 8I9H 1 JRNL REVDAT 1 07-FEB-24 8I9H 0 JRNL AUTH Y.LI,C.REN,Y.SHEN,Y.ZHANG,J.CHEN,J.ZHENG,R.TIAN,L.CAO,R.YAN JRNL TITL CRYO-EM STRUCTURES OF SARS-COV-2 BA.2-DERIVED SUBVARIANTS JRNL TITL 2 SPIKE IN COMPLEX WITH ACE2 RECEPTOR. JRNL REF CELL DISCOV V. 9 108 2023 JRNL REFN ESSN 2056-5968 JRNL PMID 37919275 JRNL DOI 10.1038/S41421-023-00607-2 REMARK 2 REMARK 2 RESOLUTION. 3.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : RELION REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.600 REMARK 3 NUMBER OF PARTICLES : 172963 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8I9H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1300035184. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : S-RBD (OMICRON XBB.1) IN REMARK 245 COMPLEX WITH PD OF ACE2; S-RBD REMARK 245 (OMICRON XBB.1); PD OF ACE2 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2200.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E, B, C, D, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 VAL A 2 REMARK 465 LYS A 3 REMARK 465 VAL A 4 REMARK 465 LEU A 5 REMARK 465 PHE A 6 REMARK 465 ALA A 7 REMARK 465 LEU A 8 REMARK 465 ILE A 9 REMARK 465 CYS A 10 REMARK 465 ILE A 11 REMARK 465 ALA A 12 REMARK 465 VAL A 13 REMARK 465 ALA A 14 REMARK 465 GLU A 15 REMARK 465 ALA A 16 REMARK 465 GLY A 17 REMARK 465 THR A 18 REMARK 465 ARG E 319 REMARK 465 VAL E 320 REMARK 465 GLN E 321 REMARK 465 PRO E 322 REMARK 465 THR E 323 REMARK 465 GLU E 324 REMARK 465 SER E 325 REMARK 465 ILE E 326 REMARK 465 VAL E 327 REMARK 465 ARG E 328 REMARK 465 PHE E 329 REMARK 465 PRO E 330 REMARK 465 ASN E 331 REMARK 465 ILE E 332 REMARK 465 THR E 333 REMARK 465 ASN E 334 REMARK 465 LEU E 335 REMARK 465 LEU E 517 REMARK 465 LEU E 518 REMARK 465 HIS E 519 REMARK 465 ALA E 520 REMARK 465 PRO E 521 REMARK 465 ALA E 522 REMARK 465 THR E 523 REMARK 465 GLY E 526 REMARK 465 PRO E 527 REMARK 465 LYS E 528 REMARK 465 LYS E 529 REMARK 465 SER E 530 REMARK 465 THR E 531 REMARK 465 ASN E 532 REMARK 465 LEU E 533 REMARK 465 VAL E 534 REMARK 465 LYS E 535 REMARK 465 ASN E 536 REMARK 465 LYS E 537 REMARK 465 CYS E 538 REMARK 465 VAL E 539 REMARK 465 ASN E 540 REMARK 465 PHE E 541 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 105 -163.82 -78.54 REMARK 500 CYS A 133 -169.88 -113.18 REMARK 500 ASN A 137 87.84 -159.11 REMARK 500 GLN A 139 18.81 -140.16 REMARK 500 HIS A 195 66.51 60.18 REMARK 500 GLU A 197 -12.32 75.99 REMARK 500 ASP A 198 175.95 179.79 REMARK 500 ASP A 213 67.31 60.14 REMARK 500 GLN A 325 -8.84 71.15 REMARK 500 ASN A 338 -70.82 -63.25 REMARK 500 GLN A 340 43.70 -145.59 REMARK 500 ASP A 427 -64.02 -95.39 REMARK 500 LEU A 444 0.80 -68.45 REMARK 500 GLN A 472 31.01 -145.89 REMARK 500 ILE A 484 -62.17 -109.04 REMARK 500 VAL A 574 -65.89 -102.74 REMARK 500 SER A 602 -167.61 -79.56 REMARK 500 ASN E 370 50.81 -119.78 REMARK 500 SER E 408 4.50 -68.68 REMARK 500 PRO E 426 -177.23 -67.44 REMARK 500 SER E 438 45.83 -140.09 REMARK 500 TYR E 449 36.69 -99.70 REMARK 500 PHE E 464 61.98 60.23 REMARK 500 ASN E 481 7.60 57.52 REMARK 500 THR E 500 55.39 -91.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-35272 RELATED DB: EMDB REMARK 900 S-RBD (OMICRON XBB.1) IN COMPLEX WITH PD OF ACE2 DBREF 8I9H A 19 615 UNP Q9BYF1 ACE2_HUMAN 19 615 DBREF 8I9H E 319 541 UNP P0DTC2 SPIKE_SARS2 319 541 SEQADV 8I9H MET A 0 UNP Q9BYF1 INITIATING METHIONINE SEQADV 8I9H GLY A 1 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H VAL A 2 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H LYS A 3 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H VAL A 4 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H LEU A 5 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H PHE A 6 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H ALA A 7 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H LEU A 8 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H ILE A 9 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H CYS A 10 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H ILE A 11 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H ALA A 12 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H VAL A 13 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H ALA A 14 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H GLU A 15 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H ALA A 16 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H GLY A 17 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H THR A 18 UNP Q9BYF1 EXPRESSION TAG SEQADV 8I9H HIS E 339 UNP P0DTC2 GLY 339 VARIANT SEQADV 8I9H THR E 346 UNP P0DTC2 ARG 346 VARIANT SEQADV 8I9H ILE E 368 UNP P0DTC2 LEU 368 VARIANT SEQADV 8I9H PHE E 371 UNP P0DTC2 SER 371 VARIANT SEQADV 8I9H PRO E 373 UNP P0DTC2 SER 373 VARIANT SEQADV 8I9H PHE E 375 UNP P0DTC2 SER 375 VARIANT SEQADV 8I9H ALA E 376 UNP P0DTC2 THR 376 VARIANT SEQADV 8I9H ASN E 405 UNP P0DTC2 ASP 405 VARIANT SEQADV 8I9H SER E 408 UNP P0DTC2 ARG 408 VARIANT SEQADV 8I9H ASN E 417 UNP P0DTC2 LYS 417 VARIANT SEQADV 8I9H LYS E 440 UNP P0DTC2 ASN 440 VARIANT SEQADV 8I9H PRO E 445 UNP P0DTC2 VAL 445 VARIANT SEQADV 8I9H SER E 446 UNP P0DTC2 GLY 446 VARIANT SEQADV 8I9H LYS E 460 UNP P0DTC2 ASN 460 VARIANT SEQADV 8I9H ASN E 477 UNP P0DTC2 SER 477 VARIANT SEQADV 8I9H LYS E 478 UNP P0DTC2 THR 478 VARIANT SEQADV 8I9H ALA E 484 UNP P0DTC2 GLU 484 VARIANT SEQADV 8I9H SER E 486 UNP P0DTC2 PHE 486 VARIANT SEQADV 8I9H SER E 490 UNP P0DTC2 PHE 490 VARIANT SEQADV 8I9H ARG E 498 UNP P0DTC2 GLN 498 VARIANT SEQADV 8I9H TYR E 501 UNP P0DTC2 ASN 501 VARIANT SEQADV 8I9H HIS E 505 UNP P0DTC2 TYR 505 VARIANT SEQRES 1 A 616 MET GLY VAL LYS VAL LEU PHE ALA LEU ILE CYS ILE ALA SEQRES 2 A 616 VAL ALA GLU ALA GLY THR SER THR ILE GLU GLU GLN ALA SEQRES 3 A 616 LYS THR PHE LEU ASP LYS PHE ASN HIS GLU ALA GLU ASP SEQRES 4 A 616 LEU PHE TYR GLN SER SER LEU ALA SER TRP ASN TYR ASN SEQRES 5 A 616 THR ASN ILE THR GLU GLU ASN VAL GLN ASN MET ASN ASN SEQRES 6 A 616 ALA GLY ASP LYS TRP SER ALA PHE LEU LYS GLU GLN SER SEQRES 7 A 616 THR LEU ALA GLN MET TYR PRO LEU GLN GLU ILE GLN ASN SEQRES 8 A 616 LEU THR VAL LYS LEU GLN LEU GLN ALA LEU GLN GLN ASN SEQRES 9 A 616 GLY SER SER VAL LEU SER GLU ASP LYS SER LYS ARG LEU SEQRES 10 A 616 ASN THR ILE LEU ASN THR MET SER THR ILE TYR SER THR SEQRES 11 A 616 GLY LYS VAL CYS ASN PRO ASP ASN PRO GLN GLU CYS LEU SEQRES 12 A 616 LEU LEU GLU PRO GLY LEU ASN GLU ILE MET ALA ASN SER SEQRES 13 A 616 LEU ASP TYR ASN GLU ARG LEU TRP ALA TRP GLU SER TRP SEQRES 14 A 616 ARG SER GLU VAL GLY LYS GLN LEU ARG PRO LEU TYR GLU SEQRES 15 A 616 GLU TYR VAL VAL LEU LYS ASN GLU MET ALA ARG ALA ASN SEQRES 16 A 616 HIS TYR GLU ASP TYR GLY ASP TYR TRP ARG GLY ASP TYR SEQRES 17 A 616 GLU VAL ASN GLY VAL ASP GLY TYR ASP TYR SER ARG GLY SEQRES 18 A 616 GLN LEU ILE GLU ASP VAL GLU HIS THR PHE GLU GLU ILE SEQRES 19 A 616 LYS PRO LEU TYR GLU HIS LEU HIS ALA TYR VAL ARG ALA SEQRES 20 A 616 LYS LEU MET ASN ALA TYR PRO SER TYR ILE SER PRO ILE SEQRES 21 A 616 GLY CYS LEU PRO ALA HIS LEU LEU GLY ASP MET TRP GLY SEQRES 22 A 616 ARG PHE TRP THR ASN LEU TYR SER LEU THR VAL PRO PHE SEQRES 23 A 616 GLY GLN LYS PRO ASN ILE ASP VAL THR ASP ALA MET VAL SEQRES 24 A 616 ASP GLN ALA TRP ASP ALA GLN ARG ILE PHE LYS GLU ALA SEQRES 25 A 616 GLU LYS PHE PHE VAL SER VAL GLY LEU PRO ASN MET THR SEQRES 26 A 616 GLN GLY PHE TRP GLU ASN SER MET LEU THR ASP PRO GLY SEQRES 27 A 616 ASN VAL GLN LYS ALA VAL CYS HIS PRO THR ALA TRP ASP SEQRES 28 A 616 LEU GLY LYS GLY ASP PHE ARG ILE LEU MET CYS THR LYS SEQRES 29 A 616 VAL THR MET ASP ASP PHE LEU THR ALA HIS HIS GLU MET SEQRES 30 A 616 GLY HIS ILE GLN TYR ASP MET ALA TYR ALA ALA GLN PRO SEQRES 31 A 616 PHE LEU LEU ARG ASN GLY ALA ASN GLU GLY PHE HIS GLU SEQRES 32 A 616 ALA VAL GLY GLU ILE MET SER LEU SER ALA ALA THR PRO SEQRES 33 A 616 LYS HIS LEU LYS SER ILE GLY LEU LEU SER PRO ASP PHE SEQRES 34 A 616 GLN GLU ASP ASN GLU THR GLU ILE ASN PHE LEU LEU LYS SEQRES 35 A 616 GLN ALA LEU THR ILE VAL GLY THR LEU PRO PHE THR TYR SEQRES 36 A 616 MET LEU GLU LYS TRP ARG TRP MET VAL PHE LYS GLY GLU SEQRES 37 A 616 ILE PRO LYS ASP GLN TRP MET LYS LYS TRP TRP GLU MET SEQRES 38 A 616 LYS ARG GLU ILE VAL GLY VAL VAL GLU PRO VAL PRO HIS SEQRES 39 A 616 ASP GLU THR TYR CYS ASP PRO ALA SER LEU PHE HIS VAL SEQRES 40 A 616 SER ASN ASP TYR SER PHE ILE ARG TYR TYR THR ARG THR SEQRES 41 A 616 LEU TYR GLN PHE GLN PHE GLN GLU ALA LEU CYS GLN ALA SEQRES 42 A 616 ALA LYS HIS GLU GLY PRO LEU HIS LYS CYS ASP ILE SER SEQRES 43 A 616 ASN SER THR GLU ALA GLY GLN LYS LEU PHE ASN MET LEU SEQRES 44 A 616 ARG LEU GLY LYS SER GLU PRO TRP THR LEU ALA LEU GLU SEQRES 45 A 616 ASN VAL VAL GLY ALA LYS ASN MET ASN VAL ARG PRO LEU SEQRES 46 A 616 LEU ASN TYR PHE GLU PRO LEU PHE THR TRP LEU LYS ASP SEQRES 47 A 616 GLN ASN LYS ASN SER PHE VAL GLY TRP SER THR ASP TRP SEQRES 48 A 616 SER PRO TYR ALA ASP SEQRES 1 E 223 ARG VAL GLN PRO THR GLU SER ILE VAL ARG PHE PRO ASN SEQRES 2 E 223 ILE THR ASN LEU CYS PRO PHE HIS GLU VAL PHE ASN ALA SEQRES 3 E 223 THR THR PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG SEQRES 4 E 223 ILE SER ASN CYS VAL ALA ASP TYR SER VAL ILE TYR ASN SEQRES 5 E 223 PHE ALA PRO PHE PHE ALA PHE LYS CYS TYR GLY VAL SER SEQRES 6 E 223 PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR SEQRES 7 E 223 ALA ASP SER PHE VAL ILE ARG GLY ASN GLU VAL SER GLN SEQRES 8 E 223 ILE ALA PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN SEQRES 9 E 223 TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA SEQRES 10 E 223 TRP ASN SER ASN LYS LEU ASP SER LYS PRO SER GLY ASN SEQRES 11 E 223 TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER LYS LEU SEQRES 12 E 223 LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN SEQRES 13 E 223 ALA GLY ASN LYS PRO CYS ASN GLY VAL ALA GLY SER ASN SEQRES 14 E 223 CYS TYR SER PRO LEU GLN SER TYR GLY PHE ARG PRO THR SEQRES 15 E 223 TYR GLY VAL GLY HIS GLN PRO TYR ARG VAL VAL VAL LEU SEQRES 16 E 223 SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY SEQRES 17 E 223 PRO LYS LYS SER THR ASN LEU VAL LYS ASN LYS CYS VAL SEQRES 18 E 223 ASN PHE HET NAG B 1 14 HET NAG B 2 14 HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET NAG F 1 14 HET NAG F 2 14 HET NAG G 1 14 HET NAG G 2 14 HET NAG H 1 14 HET NAG H 2 14 HET NAG A 701 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 13(C8 H15 N O6) HELIX 1 AA1 GLU A 22 LYS A 31 1 10 HELIX 2 AA2 GLU A 35 THR A 52 1 18 HELIX 3 AA3 THR A 55 ALA A 80 1 26 HELIX 4 AA4 GLN A 81 TYR A 83 5 3 HELIX 5 AA5 LEU A 91 GLN A 102 1 12 HELIX 6 AA6 SER A 109 THR A 129 1 21 HELIX 7 AA7 GLY A 147 SER A 155 1 9 HELIX 8 AA8 ASP A 157 GLU A 171 1 15 HELIX 9 AA9 LEU A 176 ALA A 193 1 18 HELIX 10 AB1 ASP A 198 GLY A 205 1 8 HELIX 11 AB2 GLY A 220 PHE A 230 1 11 HELIX 12 AB3 ILE A 233 MET A 249 1 17 HELIX 13 AB4 TRP A 275 TYR A 279 5 5 HELIX 14 AB5 GLN A 305 GLY A 319 1 15 HELIX 15 AB6 GLY A 326 SER A 331 1 6 HELIX 16 AB7 MET A 366 TYR A 385 1 20 HELIX 17 AB8 PRO A 389 ARG A 393 5 5 HELIX 18 AB9 GLY A 399 ALA A 412 1 14 HELIX 19 AC1 THR A 414 GLY A 422 1 9 HELIX 20 AC2 ASP A 431 LEU A 444 1 14 HELIX 21 AC3 THR A 449 LYS A 465 1 17 HELIX 22 AC4 GLN A 472 ILE A 484 1 13 HELIX 23 AC5 ASP A 499 SER A 502 5 4 HELIX 24 AC6 LEU A 503 ASN A 508 1 6 HELIX 25 AC7 ILE A 513 ALA A 533 1 21 HELIX 26 AC8 PRO A 538 CYS A 542 5 5 HELIX 27 AC9 SER A 547 ARG A 559 1 13 HELIX 28 AD1 PRO A 565 LEU A 570 1 6 HELIX 29 AD2 VAL A 581 LYS A 596 1 16 HELIX 30 AD3 PRO E 337 VAL E 341 5 5 HELIX 31 AD4 SER E 349 TRP E 353 5 5 HELIX 32 AD5 ASP E 364 ILE E 368 5 5 HELIX 33 AD6 LYS E 386 LEU E 390 5 5 HELIX 34 AD7 ARG E 403 ILE E 410 5 8 HELIX 35 AD8 SER E 438 SER E 443 1 6 SHEET 1 AA1 2 LEU A 262 PRO A 263 0 SHEET 2 AA1 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA2 2 THR A 347 GLY A 352 0 SHEET 2 AA2 2 ASP A 355 LEU A 359 -1 O LEU A 359 N THR A 347 SHEET 1 AA3 5 ASN E 354 ILE E 358 0 SHEET 2 AA3 5 ASN E 394 ILE E 402 -1 O ALA E 397 N LYS E 356 SHEET 3 AA3 5 TYR E 508 GLU E 516 -1 O TYR E 508 N ILE E 402 SHEET 4 AA3 5 CYS E 432 ASN E 437 -1 N CYS E 432 O LEU E 513 SHEET 5 AA3 5 ALA E 376 CYS E 379 -1 N ALA E 376 O ALA E 435 SHEET 1 AA4 2 LEU E 452 ARG E 454 0 SHEET 2 AA4 2 LEU E 492 SER E 494 -1 O GLN E 493 N TYR E 453 SHEET 1 AA5 2 TYR E 473 GLN E 474 0 SHEET 2 AA5 2 CYS E 488 TYR E 489 -1 O TYR E 489 N TYR E 473 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.04 SSBOND 2 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 3 CYS A 530 CYS A 542 1555 1555 2.03 SSBOND 4 CYS E 379 CYS E 432 1555 1555 2.03 SSBOND 5 CYS E 391 CYS E 525 1555 1555 2.03 SSBOND 6 CYS E 480 CYS E 488 1555 1555 2.03 LINK ND2 ASN A 53 C1 NAG B 1 1555 1555 1.44 LINK ND2 ASN A 90 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN A 103 C1 NAG D 1 1555 1555 1.44 LINK ND2 ASN A 322 C1 NAG A 701 1555 1555 1.44 LINK ND2 ASN A 432 C1 NAG F 1 1555 1555 1.45 LINK ND2 ASN A 546 C1 NAG G 1 1555 1555 1.44 LINK ND2 ASN E 343 C1 NAG H 1 1555 1555 1.43 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.43 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.45 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.45 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000